BRISTOL, RI--Convenient access to world-class cancer care has been greatly enhanced for residents of the East Bay with the opening of a Lifespan Cancer Institute location in Bristol.

A team at Rhode Island Hospital led by Lori Daiello, Pharm.D., ScM., senior research scientist at the Rhode Island Hospital Alzheimer’s Disease and Memory Disorders Center (ADMDC), will launch a groundbreaking investigation into brain health after surgery. The 5-year study, Cognitive Recovery After Elective Surgery (CREATES), is funded by a $3.8 million R01 grant from the National Institutes of Health.

Rhode Island Hospital’s Hasbro Children’s Hospital Emergency Medicine and pediatric ICU departments will be enrolling its first participants this Spring in a new, international pediatric fluid resuscitation clinical research study evaluating the comparison of Normal Saline and balanced fluids solutions in children with evidence of septic shock.

Brown invests $125M in support of integrated academic health system

PROVIDENCE, R.I. – For years, Rhode Island leaders have discussed a vision for a world-class integrated academic health system that serves the people of Rhode Island by ensuring excellence in health care from birth to end-of-life, including specialty care, in their home state. 

With the number of COVID cases dropping throughout the state, and in accordance with Rhode Island Department of Health guidance, Lifespan will be moving to a less restrictive visitation policy at our acute care hospitals. Effective Monday, February 22, we will once again be allowing limited visitation to our adult inpatient units.

Please note that there is still no visitation for COVID positive patients, except under special circumstances. If your family member is COVID-positive, please consult with the care team. 

Saul N. Weingart, M.D., assumes top role effective February 1, 2021.

Saul Weingart, MD